Katrin Schöneweis

Position-dependent splicing activation and repression by SR and hnRNP proteins rely on common mechanisms

Steffen Erkelenz, William F. Mueller, Melanie S. Evans et al. · RNA · 2012 · 242 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +16

Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial

Heiner Wedemeyer, Katrin Schöneweis, Pavel Bogomolov et al. · The Lancet Infectious Diseases · 2022 · 158 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon

Pascal Mutz, Philippe Metz, Florian A. Lempp et al. · Gastroenterology · 2018 · 151 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection

Heiner Wedemeyer, Pavel Bogomolov, Antje Blank et al. · Journal of Hepatology · 2018 · 121 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

GS-13-Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection

Heiner Wedemeyer, Katrin Schöneweis, Vladimir Chulanov et al. · Journal of Hepatology · 2019 · 121 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +8